Estrada-Capetillo and colleagues reported that moDCs from RA patients release high amounts of IL-6 and IL-23, and exhibit an increased capability to induce Th17 cells, while RA-derived TolDCs failed to induce Treg (30). Here, IL6 is linked to rheumatoid arthritis.